Xbiome

Xbiome is a leading AI pharmaceutical company in China that focuses on gut microbiota therapy, aiming to alleviate or treat intestinal and other systemic diseases through fecal microbiota transplantation, formulated bacteria, and other microbial treatment methods. Relying on an innovative drug development model and its self-developed drug discovery platform, Xbiome combines artificial intelligence with gut microbiota technology to achieve high-quality data analysis, accumulation, and output, significantly improving the efficiency and success rate of drug development. This effort effectively advances microbiome-based pharmaceuticals from scientific exploration at the laboratory stage to industrial implementation.